Quantum-Si incorporated (NASDAQ:QSI – Free Report) – Research analysts at HC Wainwright lifted their Q1 2025 earnings estimates for shares of Quantum-Si in a research report issued on Tuesday, March 4th. HC Wainwright analyst S. Ramakanth now anticipates that the company will earn ($0.17) per share for the quarter, up from their previous estimate of ($0.18). HC Wainwright has a “Buy” rating and a $5.50 price objective on the stock. The consensus estimate for Quantum-Si’s current full-year earnings is ($0.65) per share. HC Wainwright also issued estimates for Quantum-Si’s Q2 2025 earnings at ($0.16) EPS, Q3 2025 earnings at ($0.16) EPS, Q4 2025 earnings at ($0.16) EPS, FY2025 earnings at ($0.66) EPS, FY2026 earnings at ($0.60) EPS, FY2027 earnings at ($0.43) EPS and FY2028 earnings at ($0.21) EPS.
Several other equities research analysts have also commented on QSI. Alliance Global Partners assumed coverage on shares of Quantum-Si in a research report on Friday, February 7th. They set a “buy” rating and a $3.75 price target for the company. Canaccord Genuity Group reduced their price target on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday, November 13th.
Quantum-Si Stock Down 8.2 %
NASDAQ QSI opened at $1.29 on Thursday. Quantum-Si has a 52 week low of $0.61 and a 52 week high of $5.77. The firm has a market capitalization of $183.39 million, a P/E ratio of -2.01 and a beta of 2.75. The company has a 50-day moving average price of $2.22 and a 200-day moving average price of $1.45.
Institutional Investors Weigh In On Quantum-Si
A number of institutional investors have recently added to or reduced their stakes in QSI. Wolverine Asset Management LLC purchased a new stake in Quantum-Si during the 4th quarter valued at approximately $26,000. Abel Hall LLC purchased a new stake in Quantum-Si during the 4th quarter valued at approximately $28,000. Dudley Capital Management LLC purchased a new stake in Quantum-Si during the 4th quarter valued at approximately $30,000. Jump Financial LLC purchased a new stake in Quantum-Si during the 4th quarter valued at approximately $33,000. Finally, Balyasny Asset Management L.P. purchased a new stake in Quantum-Si during the 4th quarter valued at approximately $36,000. 39.90% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In related news, Director Jonathan M. Rothberg sold 3,506,267 shares of the stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $3.34, for a total value of $11,710,931.78. Following the completion of the sale, the director now directly owns 1,250,000 shares of the company’s stock, valued at approximately $4,175,000. This represents a 73.72 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 30.04% of the stock is currently owned by insiders.
Quantum-Si Company Profile
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Featured Stories
- Five stocks we like better than Quantum-Si
- How to Short Nasdaq: An Easy-to-Follow Guide
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- Where to Find Earnings Call Transcripts
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.